Biogen's Chief Accounting Officer Sean Godbout Reports October 2026 Stock Transactions via Form 4
Alpha Vantage · Kalkine Media · · AI-summarised by FinFlash
Biogen's Chief Accounting Officer Sean Godbout filed a Form 4 detailing his October 2026 equity transactions. These included the grant of 985 restricted stock units, the conversion of 27 RSUs into common stock, and the sale of 8 shares to cover tax withholdings. Following these transactions, Godbout directly held 1,458.9845 shares of Biogen common stock.
Understand the context
Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.